Consensus Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 01:58:35 2026-01-22 am EST			5-day change	1st Jan Change
884.95 ^INR	+0.99%		+0.11%	-3.24%

12:23am	Zydus Lifesciences Launches Nivolumab Biosimilar in India	MT
11:56pm	Zydus Lifesciences launches biosimilar of Nivolumab in India	RE

Evolution of the Average Target: Zydus Lifesciences Limited

Evolution of the Target Price: Zydus Lifesciences Limited

Changes in Analyst Recommendations: Zydus Lifesciences Limited

8e1dfc6e2bf5cdda2c45fb47.F4V0i78vryk7D8SlRsZfIspc7RyYuuQugTsupFXFQb4.IMQXwelZ4BFYPYboDZYGVoFvgy3Z7I4W6WRr8B-xOId24B_i2X73H21WlQ~bbc293bb05d91cb5414080df4f7fb56c

Analysts' recommendations: Zydus Lifesciences Limited

Nov. 07	Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,120 From INR1,150, Keeps at Buy	MT
Nov. 04	Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Budesonide Delayed-Release Capsules, 4 Mg	CI
25-05-21	Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,150 From INR1,350, Keeps at Buy	MT
25-03-10	Zydus Lifesciences Limited entered into a tender offer agreement to acquire 14.40% stake in Amplitude Surgical SA for ?43.2 million.	CI
25-02-06	Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,350 From INR1,380, Keeps at Buy	MT
25-01-10	Nomura Upgrades Zydus Lifesciences to Buy From Neutral, Adjusts Price Target to INR1,140 From INR1,030	MT
24-11-14	Nomura Adjusts Zydus Lifesciences' Price Target to INR1,030 From INR1,020, Keeps at Neutral	MT
24-11-13	Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,380 From INR1,450, Keeps at Buy	MT
24-08-28	Jefferies Upgrades Zydus Lifesciences to Buy From Hold, Adjusts Price Target to INR1,450 From INR1,210	MT
24-08-12	Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,210 From INR1,070, Keeps at Hold	MT
24-05-21	Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988	MT
24-05-20	Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold	MT
24-02-12	Jefferies Adjusts Zydus Lifesciences’ Price Target to INR750 From INR660, Keeps at Hold	MT
23-11-08	Jefferies Adjusts Zydus Lifesciences’ Price Target to INR640 From INR630, Keeps at Hold	MT
23-08-15	Nomura Adjusts Zydus Lifesciences' Price Target to INR747 From INR540, Keeps at Buy	MT
23-08-14	Jefferies Downgrades Zydus Lifesciences to Hold From Buy, Adjusts Price Target to INR630 From INR585	MT
23-05-19	Jefferies Adjusts Zydus Lifesciences' Price Target to INR585 From INR575, Keeps at Buy	MT
23-02-07	Nomura Adjusts Zydus Lifesciences' Price Target to INR540 From INR489, Keeps at Buy	MT
22-02-07	Nomura Adjusts Cadila Healthcare's Price Target to 489 Indian Rupees From 481 Indian Rupees, Keeps at Buy	MT
21-08-23	Mindtree : Indian shares reverse gains as metals drag; Cadila jumps	RE
15-05-15	Cadila Healthcare Ltd Recommends Dividend for the Year Ended March 31, 2015, payable on or after August 17, 2015	CI
12-05-09	Cadila Healthcare Limited Recommends Dividend	CI

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' Target price divergence	Objective/dr gap
ZYDUS LIFESCIENCES LIMITED		+15.67%
SUN PHARMACEUTICAL INDUSTRIES LTD.		+21.85%
OTSUKA HOLDINGS CO., LTD.		+10.77%
CIPLA LIMITED		+19.82%
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-	+16.5%
KRKA, D. D.		-12.38%
ONO PHARMACEUTICAL CO., LTD.		-19.77%
GLENMARK PHARMACEUTICALS LIMITED		+13.25%
Average		+8.22%
Weighted average by Cap.		+13.23%